Skip to main content
. 2022 Sep 12;12:982948. doi: 10.3389/fonc.2022.982948

Figure 1.

Figure 1

Flow chart illustrating the selection of patients; TACE-LEN-C, transcatheter arterial chemoembolization with lenvatinib plus camrelizumab; TACE-LEN, transcatheter arterial chemoembolization with LEN.